Our News
Celebrating Alnylam's 1000th Employee!
November 8, 2018
Alnylam Pharmaceuticals
We were founded 16 years ago on the belief that we could translate the Nobel Prize-winning discovery of RNA interference (#RNAi) into an entirely new class of medicines with the potential to improve the lives of people living with rare and genetic diseases. Earlier this year, we marked the milestone of our first approved medicine in the U.S. and EU. It hasn’t been an easy journey, but over the years, we’ve been fortunate to the be able to attract many amazing Alnylamites who have said “Challenge Accepted!” and they’ve made our achievements possible.
Celebrating 1000 (and Counting) Employees!
